HOLOGIC INC (HOLX) Stock Price, Forecast & Analysis

NASDAQ:HOLX • US4364401012

75.43 USD
+0.29 (+0.39%)
At close: Feb 20, 2026
75.43 USD
0 (0%)
After Hours: 2/20/2026, 8:00:01 PM

HOLX Key Statistics, Chart & Performance

Key Statistics
Market Cap16.84B
Revenue(TTM)4.13B
Net Income(TTM)543.80M
Shares223.24M
Float221.38M
52 Week High75.47
52 Week Low51.9
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)4.28
PE17.62
Fwd PE14.99
Earnings (Next)04-29
IPO1990-03-01
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
HOLX short term performance overview.The bars show the price performance of HOLX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 2 4 6 8 10

HOLX long term performance overview.The bars show the price performance of HOLX in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 5 -5 10 15

The current stock price of HOLX is 75.43 USD. In the past month the price increased by 0.43%. In the past year, price increased by 16.96%.

HOLOGIC INC / HOLX Daily stock chart

HOLX Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to HOLX. When comparing the yearly performance of all stocks, HOLX turns out to be only a medium performer in the overall market: it outperformed 59.59% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
HOLX Full Technical Analysis Report

HOLX Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to HOLX. Both the health and profitability get an excellent rating, making HOLX a very profitable company, without any liquidiy or solvency issues.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
HOLX Full Fundamental Analysis Report

HOLX Financial Highlights

Over the last trailing twelve months HOLX reported a non-GAAP Earnings per Share(EPS) of 4.28. The EPS increased by 3.68% compared to the year before.


Industry RankSector Rank
PM (TTM) 13.18%
ROA 5.92%
ROE 10.37%
Debt/Equity 0.48
Chartmill High Growth Momentum
EPS Q2Q%1.17%
Sales Q2Q%2.54%
EPS 1Y (TTM)3.68%
Revenue 1Y (TTM)2.17%
HOLX financials

HOLX Forecast & Estimates

23 analysts have analysed HOLX and the average price target is 76.89 USD. This implies a price increase of 1.94% is expected in the next year compared to the current price of 75.43.

For the next year, analysts expect an EPS growth of 7.54% and a revenue growth 3.07% for HOLX


Analysts
Analysts55.65
Price Target76.89 (1.94%)
EPS Next Y7.54%
Revenue Next Year3.07%
HOLX Analyst EstimatesHOLX Analyst Ratings

HOLX Ownership

Ownership
Inst Owners99.52%
Ins Owners0.85%
Short Float %1.87%
Short Ratio1.55
HOLX Ownership

HOLX Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
ABT ABBOTT LABORATORIES19.54195.119B
ISRG INTUITIVE SURGICAL INC49.31179.003B
SYK STRYKER CORP25.15145.408B
BSX BOSTON SCIENTIFIC CORP21.29110.604B
BDX BECTON DICKINSON AND CO11.7752.82B
IDXX IDEXX LABORATORIES INC42.950.758B
EW EDWARDS LIFESCIENCES CORP26.8346.296B
GEHC GE HEALTHCARE TECHNOLOGY16.7738.388B
RMD RESMED INC21.137.749B
DXCM DEXCOM INC28.9428.503B

About HOLX

Company Profile

HOLX logo image Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focus on women’s health and well-being through early detection and treatment. The company is headquartered in Marlborough, Massachusetts and currently employs 7,070 full-time employees. The firm is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.

Company Info

HOLOGIC INC

250 Campus Drive

Marlborough MASSACHUSETTS 01752 US

CEO: STEPHEN P. MACMILLAN

Employees: 7063

HOLX Company Website

HOLX Investor Relations

Phone: 13026587581

HOLOGIC INC / HOLX FAQ

Can you describe the business of HOLOGIC INC?

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focus on women’s health and well-being through early detection and treatment. The company is headquartered in Marlborough, Massachusetts and currently employs 7,070 full-time employees. The firm is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.


What is the stock price of HOLOGIC INC today?

The current stock price of HOLX is 75.43 USD. The price increased by 0.39% in the last trading session.


Does HOLOGIC INC pay dividends?

HOLX does not pay a dividend.


What is the ChartMill rating of HOLOGIC INC stock?

HOLX has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


What is the analyst forecast for HOLX stock?

23 analysts have analysed HOLX and the average price target is 76.89 USD. This implies a price increase of 1.94% is expected in the next year compared to the current price of 75.43.


Can you provide the number of employees for HOLOGIC INC?

HOLOGIC INC (HOLX) currently has 7063 employees.